Ukko Revenue and Competitors

Tel Aviv, Israel

Location

$47.7M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Ukko's estimated annual revenue is currently $12.1M per year.(i)
  • Ukko's estimated revenue per employee is $155,000
  • Ukko's total funding is $47.7M.

Employee Data

  • Ukko has 78 Employees.(i)
  • Ukko grew their employee count by 7% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$31.6M198N/AN/AN/A
Add Company

Ukko is improving the lives of millions that suffer from food allergies and disorders. We are using cutting edge technologies in immunology, computational biology, and plant science to develop a new approach. We have offices in Tel Aviv, Israel and Palo Alto, California.

keywords:N/A

$47.7M

Total Funding

78

Number of Employees

$12.1M

Revenue (est)

7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ukko News

2022-04-17 - Buffalo Sabres: What is the right decision at goaltender?

In 2021-22, the Sabres had a revolving door that included stints from Ukko-Pekka Luukkonen, Michael Houser, Aaron Dell, and Malcolm Subban.

2022-04-13 - After rough stretch, Sabres prospect Ukko-Pekka Luukkonen ...

After rough stretch, Sabres prospect Ukko-Pekka Luukkonen thriving. ROCHESTER – When Matthew Peca jumped off the bench, one-timed a rolling puck...

2022-03-30 - Sabres' Kevyn Adams happy with goalie prospect Ukko-Pekka ...

BUFFALO – In assessing Ukko-Pekka Luukkonen's play, Sabres general manager Kevyn Adams looks beyond the suspect numbers the goalie prospect has compiled.

2021-01-28 - Ukko Raises $40M in Series B Funding

Ukko, a Tel Aviv, Israel-based biotech company with the mission to eliminate food allergies and sensitivities, raised $40m in Series B funding. The round was led by Leaps by Bayer, and was joined by Continental Grain Company, PeakBridge Ventures, Skyviews Life Science and Fall Line Capital, as ...

2021-01-27 - Ukko raises $40 million to address food allergies with AI

Ukko, a 30-employee biotech company using AI to investigate solutions for food allergies and sensitivities, today raised $40 million in a series B round led by Bayer’s Leaps by Bayer. Ukko says the new funding will allow it to enter clinical trials with an investigational therapeutic for peanut ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A7837%N/A
#2
$11.3M7824%N/A
#3
$15.7M78-4%N/A
#4
$11.3M78-4%N/A
#5
$21.3M7955%N/A